neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
📊
Treatment Reviews
See user reviews and ratings for neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
🔬
Mega-Study
See real-world data analysis for neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
📚
Meta-Analysis
See a meta-analysis of all available research
🔍
Clinical Trials
See clinical trials related to neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)